HealthStream | 8-K: FY2025 Q2 Revenue Beats Estimate at USD 74.4 M

LB filings
2025.08.04 20:36
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q2, the actual value is USD 74.4 M, beating the estimate of USD 74.39 M.

EPS: As of FY2025 Q2, the actual value is USD 0.18, beating the estimate of USD 0.156.

EBIT: As of FY2025 Q2, the actual value is USD 6.867 M, beating the estimate of USD 5.391 M.

Financial Metrics Summary

Revenue

  • Total revenue for the second quarter of 2025 was $74.4 million, marking a 4.0% increase from $71.6 million in the second quarter of 2024.
  • Subscription revenues increased by $2.9 million, or 4.2%, while professional services revenues decreased by $0.1 million compared to the second quarter of 2024.
  • Revenues for the first six months of 2025 were $147.9 million, an increase of 2.5% over revenues of $144.3 million for the first six months of 2024.

Operating Income

  • Operating income for the second quarter of 2025 was $5.9 million, up 33.4% from $4.4 million in the second quarter of 2024.
  • Operating income for the first six months of 2025 increased by 1.6% to $10.3 million, compared to $10.1 million for the first six months of 2024.

Net Income

  • Net income for the second quarter of 2025 was $5.4 million, an increase of 29.3% from $4.2 million in the second quarter of 2024.
  • Net income for the first six months of 2025 increased to $9.7 million, compared to $9.4 million for the first six months of 2024.

Adjusted EBITDA

  • Adjusted EBITDA for the second quarter of 2025 was $17.6 million, up 11.3% from $15.8 million in the second quarter of 2024.
  • Adjusted EBITDA increased by 2.8% to $33.8 million for the first six months of 2025, compared to $32.9 million for the first six months of 2024.

Cash Flow

  • Net cash provided by operating activities for the six months ended June 30, 2025, was $32.1 million, compared to $27.4 million for the same period in 2024.
  • Net cash used in investing activities was - $18.4 million for the six months ended June 30, 2025.
  • Net cash used in financing activities was - $21.1 million for the six months ended June 30, 2025.

Financial Outlook for 2025

  • The Company projects full-year 2025 revenue to be between $297.5 million and $303.5 million.
  • Net income is expected to range from $19.5 million to $22.4 million.
  • Adjusted EBITDA is projected to be between $68.5 million and $72.5 million.
  • Capital expenditures are anticipated to be between $31.0 million and $34.0 million.